EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

In Vitro Effects of Cabazitaxel and Menadione on Cell Growth, Metabolism, and Transcriptomic Profile of Human Prostate Cancer Cell Lines

Ana Laura Gómez-Rosas iD, Mayel Chirinos iD, Nancy Noyola-Martínez iD, Mariana Segovia-Mendoza iD, Nayeli Torres-Ramírez iD, Sandra Romero-Córdoba iD, Lilia G Noriega iD, Mitzi García-Olivares iD, Fernando Larrea iD, David Barrera iD

Prostate Cancer · 2026-01 · 2026 (1)

DOI: 10.1155/proc/4174599 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Prostate Cancer, online erschienen am 17.05.2026. Verfasst von Ana Laura Gómez-Rosas und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Reproductive Biology "Dr. Carlos Gual Castro", Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico…. Die Arbeit nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cabazitaxel is a second‐generation semisynthetic taxane approved for the treatment of prostate cancer. Vitamin K, an essential nutrient involved in blood coagulation and bone metabolism, has also been shown to have antineoplastic effects. However, no information is currently available regarding the combinatorial effects of cabazitaxel and menadione (VK3, a derivative of vitamin K) on prostate cancer cells. Therefore, we investigated the in vitro effects of cabazitaxel, VK3, and their combination on growth, mitochondrial bioenergetics, and glycolytic parameters using the human prostate cancer cell lines PC‐3 and DU 145. All treatments inhibited the cell growth, but the combination of cabazitaxel and VK3 produced a synergistic effect that was stronger than either compound alone, and these effects were accompanied by cell line–specific bioenergetic changes and glycolytic responses. Furthermore, high‐throughput transcriptomic profiling of PC‐3 cells revealed distinct sets of differentially expressed genes for each treatment, with the greatest effect established by the combinatorial treatment, followed by VK3, and then cabazitaxel. Gene ontology analyses showed that the combinatorial treatment was associated with biological processes such as positive regulation of reactive oxygen species metabolic process, steroid metabolic process, proteolysis, and signal transduction. Notably, the treatments altered the gene expression of several tumorigenic and immunologic mediators, including MSXI , ZRSR2 , GALNTL6 , IL24 , and IL18R1 , which may impact cancer cell behavior. In conclusion, these in vitro findings indicate that the combination of cabazitaxel with VK3 is more effective in inhibiting prostate cancer cell growth than either agent alone and provide exploratory mechanistic insight into their effects on cancer cell metabolism and gene expression.

Schlagwörter

Stichwörter der Autor:innen

IL18R1IL24cabazitaxelmenadionemicroarrayprostate cancerreactive oxygen species

Autor:innen und Institutionen

  • Department of Reproductive Biology "Dr. Carlos Gual Castro", Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico, innsz.mx.
  • Department of Pharmacology, Faculty of Medicine, Universidad Nacional Autónoma de México, Mexico City, Mexico, unam.mx.
  • Department of Cell Biology, Faculty of Sciences, Universidad Nacional Autónoma de México, Mexico City, Mexico, unam.mx.
  • Department of Genomic Medicine and Environmental Toxicology, Institute of Biomedical Research, Universidad Nacional Autónoma de México, Mexico City, Mexico, unam.mx.
  • Department of Biochemistry, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico, innsz.mx.
  • Department of Nutritional Physiology, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico, innsz.mx.

ORCID-Profile: Ana Laura Gómez-Rosas, Mayel Chirinos, Nancy Noyola-Martínez, Mariana Segovia-Mendoza, Nayeli Torres-Ramírez, Sandra Romero-Córdoba, Lilia G Noriega, Mitzi García-Olivares, Fernando Larrea, David Barrera

Zitieren

APA

Gómez-Rosas, A. L., Chirinos, M., Noyola-Martínez, N., Segovia-Mendoza, M., Torres-Ramírez, N., Romero-Córdoba, S., Noriega, L. G., García-Olivares, M., Larrea, F., & Barrera, D. (2026). In Vitro Effects of Cabazitaxel and Menadione on Cell Growth, Metabolism, and Transcriptomic Profile of Human Prostate Cancer Cell Lines. Prostate Cancer, 2026(1). https://doi.org/10.1155/proc/4174599

Vancouver

Gómez-Rosas AL, Chirinos M, Noyola-Martínez N, Segovia-Mendoza M, Torres-Ramírez N, Romero-Córdoba S, et al. In Vitro Effects of Cabazitaxel and Menadione on Cell Growth, Metabolism, and Transcriptomic Profile of Human Prostate Cancer Cell Lines. Prostate Cancer. 2026;2026(1). doi:10.1155/proc/4174599

BibTeX
@article{GmezRosas2026,
  author = {Gómez-Rosas, Ana Laura and Chirinos, Mayel and Noyola-Martínez, Nancy and Segovia-Mendoza, Mariana and Torres-Ramírez, Nayeli and Romero-Córdoba, Sandra and Noriega, Lilia G and García-Olivares, Mitzi and Larrea, Fernando and Barrera, David},
  title = {In Vitro Effects of Cabazitaxel and Menadione on Cell Growth, Metabolism, and Transcriptomic Profile of Human Prostate Cancer Cell Lines},
  journal = {Prostate Cancer},
  year = {2026},
  volume = {2026},
  number = {1},
  doi = {10.1155/proc/4174599}
}
Kostenlos starten →